Annals of Pediatric Endocrinology & Metabolism10.6065/apem.2013.18.4.1732013184173Multicenter clinical trial of leuprolide acetate depot (Luphere depot 3.75 mg) for efficacy and safety in girls with central precocious pubertyYou Jin Kim, Hae Sang Lee, Young Jun Lee, Jung Sub Lim, Se Young Kim, Eun Young Kim, Dong Kyu Jin, Il Tae Hwang, Jin Soon Hwang
Journal of the Endocrine Society10.1210/jendso/bvad071202377Efficacy and Safety of Leuprolide Acetate 6-Month Depot for the Treatment of Central Precocious Puberty: A Phase 3 StudyKaren O Klein, Nelly Mauras, Sunil Nayak, Bhuvana Sunil, Blanca M Martinez-Placencia, Sanja Dragnic, Mayra Ballina, Qing Zhou, Alvina R Kansra,,
Clinical Drug Investigation10.1007/s40261-014-0193-22014347441-448Pharmacokinetic and Exposure–Response Analyses of Leuprolide Following Administration of Leuprolide Acetate 3-Month Depot Formulations to Children with Central Precocious PubertyNael M. Mostafa, Balakrishna Hosmane, Lois M. Larsen, Kristof Chwalisz, Yi-Lin Chiu, Rajendra S. Pradhan,,
International Journal of Pediatric Endocrinology10.1186/1687-9856-2011-7201120111Efficacy of Leuprolide Acetate 1-Month Depot for Central Precocious Puberty (CPP): Growth Outcomes During a Prospective, Longitudinal StudyPeter A Lee, E Kirk Neely, John Fuqua, Di Yang, Lois M Larsen, Cynthia Mattia-Goldberg, Kristof Chwalisz,,
The Journal of Pediatrics10.1016/s0022-3476(05)81162-x19921214634-640Two-year results of treatment with depot leuprolide acetate for central precocious pubertyE.K. Neely, R.L. Hintz, B. Parker, L.K. Bachrach, P. Cohen, R. Olney, D.M. Wilson,
Urology10.1016/j.urology.2009.07.13422009744S133MP-18.07: Phase III Efficacy and Safety Trial of a New Leuprolide Acetate 3.75 Mg Depot Formulation in Prostate Cancer PatientsA. Kaisary, C. Savulsky, N. Shore, G. Karlin, R. Mis, C. Leuratti, M. Marberger,
The Journal of Pediatrics10.1016/j.jpeds.2011.05.03620111596982-987.e1A Randomized Trial of 1- and 3-Month Depot Leuprolide Doses in the Treatment of Central Precocious PubertyKimberly Fuld, Carolyn Chi, E. Kirk Neely,
The Journal of Pediatrics10.1016/s0022-3476(05)81720-219931232334-335Local reactions to depot leuprolide therapy for central precocious pubertyPenelope K. Manasco, Ora H. Pescovitz, Robert M. Blizzard,
Journal of Korean Medical Science10.3346/jkms.2021.36.e21920213634Efficacy of Triptorelin 3-Month Depot Compared to 1-Month Depot for the Treatment of Korean Girls with Central Precocious Puberty in Single Tertiary CenterLindsey Yoojin Chung, Eungu Kang, Hyo-Kyoung Nam, Young-Jun Rhie, Kee-Hyoung Lee,,
International Journal of Endocrinology10.1155/2022/1043293202220221-8Efficacy of Leuprorelin 3-Month Depot (11.25 mg) Compared to 1-Month Depot (3.75 mg) for Central Precocious Puberty in Chinese Girls: A Prospective Cohort StudyJianmei Yang, Qijun Song, Shuo Gao, Yuye Gao, Xiaohong Shang, Guimei Li, Yan Sun, Xiaoping Luo,,